Automated quantification of 18F-flutemetamol PET activity for categorizing scans as negative or positive for brain amyloid: concordance with visual image reads.
about
Optimized classification of 18F-Florbetaben PET scans as positive and negative using an SUVR quantitative approach and comparison to visual assessment.Deformation field correction for spatial normalization of PET imagesDiagnostic value of cerebrospinal fluid Aβ ratios in preclinical Alzheimer's diseaseIncreased amyloidogenic APP processing in APOE ɛ4-negative individuals with cerebral β-amyloidosis.Post-mortem histopathology underlying β-amyloid PET imaging following flutemetamol F 18 injection.From Neurodegeneration to Brain Health: An Integrated Approach.Functional Changes in the Language Network in Response to Increased Amyloid β Deposition in Cognitively Intact Older Adults.Imaging β-amyloid using [(18)F]flutemetamol positron emission tomography: from dosimetry to clinical diagnosis.Comparison of [18F]Flutemetamol and [11C]Pittsburgh Compound-B in cognitively normal young, cognitively normal elderly, and Alzheimer's disease dementia individuals.Contributions of imprecision in PET-MRI rigid registration to imprecision in amyloid PET SUVR measurements.A new integrated dual time-point amyloid PET/MRI data analysis method.Amyloid Imaging: Poised for Integration into Medical Practice.Evaluation of software tools for automated identification of neuroanatomical structures in quantitative β-amyloid PET imaging to diagnose Alzheimer's disease.Subjective Memory Complaints in APOEɛ4 Carriers are Associated with High Amyloid-β Burden.An exploratory efficacy study of the amyloid imaging agent [(18)F]flutemetamol in Japanese Subjects.Performance of [18F]flutemetamol amyloid imaging against the neuritic plaque component of CERAD and the current (2012) NIA-AA recommendations for the neuropathologic diagnosis of Alzheimer's disease.Short-Term Practice Effects and Amyloid Deposition: Providing Information Above and Beyond Baseline Cognition.Evaluation of Cholinergic Deficiency in Preclinical Alzheimer's Disease Using Pupillometry.Amyloid Positivity Using [18F]Flutemetamol-PET and Cognitive Deficits in Nondemented Community-Dwelling Older Adults.Cerebrospinal Fluid, MRI, and Florbetaben-PET in Cerebral Amyloid Angiopathy-Related Inflammation.Evaluation of Cholinergic Deficiency in Preclinical Alzheimer's Disease Using Pupillometry.Optimizing PiB-PET SUVR change-over-time measurement by a large-scale analysis of longitudinal reliability, plausibility, separability, and correlation with MMSE.Evaluation of amyloid status in a cohort of elderly individuals with memory complaints: validation of the method of quantification and determination of positivity thresholds.Relationship between 18F-Flutemetamol uptake and RBANS performance in non-demented community-dwelling older adults.Inter-rater variability of visual interpretation and comparison with quantitative evaluation of 11C-PiB PET amyloid images of the Japanese Alzheimer's Disease Neuroimaging Initiative (J-ADNI) multicenter study.Amyloid imaging in cognitively normal older adults: comparison between (18)F-flutemetamol and (11)C-Pittsburgh compound B.Yes we can analyse amyloid images - Now What?Data driven diagnostic classification in Alzheimer's disease based on different reference regions for normalization of PiB-PET images and correlation with CSF concentrations of Aβ species
P2860
Q33714693-F7A49948-DF51-4CC7-BB81-A2EC6512280FQ36042353-4AFB5F57-EE68-428C-B31C-371C229E3FA0Q36383749-38E97EC6-5EF7-48BD-9E49-BE8E17850A53Q36674545-DC775D04-DAAE-4659-8910-6E2BE6857120Q37498339-2766EBEA-DCD5-4D12-9894-14785FDD2E76Q38365566-1A2530C4-F22E-436A-8EB6-F3EFC6BB20D0Q38419997-F16B4E56-6DCF-4248-8E4F-349744114307Q38600277-95A7FDE7-8CC4-4242-B945-E1F0F528988AQ38601321-FB67B17A-3216-4720-8595-1D4974A37C4DQ38692086-7B6C20D8-5CDD-44DC-BB1A-AEE532857033Q38694948-D4AEA02A-4ABB-478A-A9A1-680F45ECC1DCQ38939875-C0840E07-7579-44D3-AA2B-9937DE264959Q40135278-12AE9CD5-5AC0-45FC-99C3-5442C32E59FAQ40335688-BC113564-AF1F-4689-AB42-40F6F301022AQ41072137-6562EF29-4C92-4E3B-AE48-4785CE169241Q41189152-6696E29A-1BC1-41F0-9B9C-7034AB698D40Q41686078-C822D124-7D4E-4F72-9BD8-DE2D04CD065FQ47102335-C38A5F8F-095E-4BBA-AE7A-92B287506DF4Q47127718-5554CC62-0BBE-483E-A372-F96377DE0A80Q47288867-F9B47047-6583-4865-B037-07A39C033FAAQ47624401-CB7B987F-9F76-42FA-88F0-F0212713D591Q47905334-3A3385DD-02F4-4A50-A63B-7FEE7F9791B7Q47926987-B6320CA1-D2DD-4F9C-A8DB-85F65A6EBE89Q47995397-7B3DF7B9-6F75-4154-8EAB-38C8A37366EDQ48158298-458E5BD7-FC7F-4A64-A3E8-291A5D1E30D2Q48759194-CCD27D46-C913-45C9-8B95-759DCCFF6358Q51142911-495EED6E-99F1-4DCB-A35C-1B04AB6AE204Q58766037-260AAE69-B9D7-4C2F-8674-9AC4C94397EA
P2860
Automated quantification of 18F-flutemetamol PET activity for categorizing scans as negative or positive for brain amyloid: concordance with visual image reads.
description
2014 nî lūn-bûn
@nan
2014年の論文
@ja
2014年学术文章
@wuu
2014年学术文章
@zh
2014年学术文章
@zh-cn
2014年学术文章
@zh-hans
2014年学术文章
@zh-my
2014年学术文章
@zh-sg
2014年學術文章
@yue
2014年學術文章
@zh-hant
name
Automated quantification of 18 ...... dance with visual image reads.
@en
Automated quantification of 18 ...... dance with visual image reads.
@nl
type
label
Automated quantification of 18 ...... dance with visual image reads.
@en
Automated quantification of 18 ...... dance with visual image reads.
@nl
prefLabel
Automated quantification of 18 ...... dance with visual image reads.
@en
Automated quantification of 18 ...... dance with visual image reads.
@nl
P2093
P1476
Automated quantification of 18 ...... dance with visual image reads.
@en
P2093
Chris Buckley
Johan Lilja
Lennart Thurfjell
Paul Sherwin
Roger Lundqvist
P304
P356
10.2967/JNUMED.114.142109
P407
P577
2014-08-21T00:00:00Z